Myriad Genetics
MYGN
MYGN
275 hedge funds and large institutions have $6.54B invested in Myriad Genetics in 2014 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 87 increasing their positions, 112 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
26% less call options, than puts
Call options by funds: $43.8M | Put options by funds: $59.4M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
275
Holding in Top 10
3
Calls
$43.8M
Puts
$59.4M
Top Buyers
| 1 | +$91M | |
| 2 | +$27.4M | |
| 3 | +$26.6M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$11.4M |
| 5 |
TCM
Tieton Capital Management
Yakima,
Washington
|
+$10.1M |
Top Sellers
| 1 | -$51.8M | |
| 2 | -$41.9M | |
| 3 | -$30.5M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$26.4M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$20.6M |